Cyclacel Pharmaceuticals, Inc. announced a 1-for-15 reverse stock split of its common stock, effective July 7, 2025, with trading commencing on a split-adjusted basis that day under the ticker symbol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results